JP2002541800A5 - - Google Patents

Download PDF

Info

Publication number
JP2002541800A5
JP2002541800A5 JP2000611669A JP2000611669A JP2002541800A5 JP 2002541800 A5 JP2002541800 A5 JP 2002541800A5 JP 2000611669 A JP2000611669 A JP 2000611669A JP 2000611669 A JP2000611669 A JP 2000611669A JP 2002541800 A5 JP2002541800 A5 JP 2002541800A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000611669A
Other versions
JP2002541800A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/010039 external-priority patent/WO2000061746A1/en
Publication of JP2002541800A publication Critical patent/JP2002541800A/ja
Publication of JP2002541800A5 publication Critical patent/JP2002541800A5/ja
Pending legal-status Critical Current

Links

JP2000611669A 1999-04-12 2000-04-12 前立腺癌において発現される１３回膜貫通タンパク質 Pending JP2002541800A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12885899P 1999-04-12 1999-04-12
US60/128,858 1999-04-12
PCT/US2000/010039 WO2000061746A1 (en) 1999-04-12 2000-04-12 13 transmembrane protein expressed in prostate cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007161935A Division JP2007314543A (ja) 1999-04-12 2007-06-19 前立腺癌において発現される１３回膜貫通タンパク質

Publications (2)

Publication Number Publication Date
JP2002541800A JP2002541800A (ja) 2002-12-10
JP2002541800A5 true JP2002541800A5 (ja) 2005-12-15

Family

ID=22437339

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2000611669A Pending JP2002541800A (ja) 1999-04-12 2000-04-12 前立腺癌において発現される１３回膜貫通タンパク質
JP2007161935A Pending JP2007314543A (ja) 1999-04-12 2007-06-19 前立腺癌において発現される１３回膜貫通タンパク質
JP2009269211A Pending JP2010051321A (ja) 1999-04-12 2009-11-26 前立腺癌において発現される１３回膜貫通タンパク質
JP2012269226A Pending JP2013136574A (ja) 1999-04-12 2012-12-10 前立腺癌において発現される１３回膜貫通タンパク質

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2007161935A Pending JP2007314543A (ja) 1999-04-12 2007-06-19 前立腺癌において発現される１３回膜貫通タンパク質
JP2009269211A Pending JP2010051321A (ja) 1999-04-12 2009-11-26 前立腺癌において発現される１３回膜貫通タンパク質
JP2012269226A Pending JP2013136574A (ja) 1999-04-12 2012-12-10 前立腺癌において発現される１３回膜貫通タンパク質

Country Status (6)

Country Link
EP (2) EP2365081A3 (ja)
JP (4) JP2002541800A (ja)
AU (2) AU780061B2 (ja)
CA (1) CA2369413C (ja)
IL (3) IL145775A0 (ja)
WO (1) WO2000061746A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6943235B1 (en) 1999-04-12 2005-09-13 Agensys, Inc. Transmembrane protein expressed in prostate cancer
US7244827B2 (en) 2000-04-12 2007-07-17 Agensys, Inc. Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
JP2004523236A (ja) * 2001-02-16 2004-08-05 インサイト・ゲノミックス・インコーポレイテッド 神経伝達関連タンパク質
EP1565200A4 (en) * 2002-11-27 2009-06-24 Agensys Inc NUCLEIC ACID 24P4C12 AND CORRESPONDING PROTEIN FOR THE TREATMENT AND DETECTION OF CANCER
WO2009033094A2 (en) * 2007-09-07 2009-03-12 Agensys, Inc. Antibodies and related molecules that bind to 24p4c12 proteins
EP2403524A4 (en) 2009-03-06 2012-09-26 Agensys Inc CONJUGATES ANTIBODY-DRUG (ADC) BINDING PROTEINS 24P4C12
JP5122592B2 (ja) * 2010-01-04 2013-01-16 アジェンシス，インコーポレイテッド 癌の処置および検出において有用な２４ｐ４ｃ１２と称される、核酸および対応タンパク質
WO2016001485A1 (en) 2014-06-30 2016-01-07 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
ES2952779T3 (es) 2017-05-18 2023-11-06 Modernatx Inc ARN mensajero modificado que comprende elementos de ARN funcionales

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866A (en) 1984-06-22 1988-04-12 President And Fellows Of Harvard College Transgenic non-human mammals
EP0206448B1 (en) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
CA2064555A1 (en) 1990-06-27 1991-12-28 Arnold J. Levine Probes for detecting mutant p53
US5733731A (en) 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
CH686982A5 (fr) 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
DK0773952T3 (da) 1994-07-20 2004-03-22 Inst Genetics Llc Interaktionsfældesystemer til påvisning af proteininteraktioner
US5919652A (en) 1994-11-09 1999-07-06 The Regents Of The University Of California Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
ATE352638T1 (de) 1995-04-11 2007-02-15 Gen Hospital Corp REVERSE ßTWO-HYBRIDß-SYSTEME
ES2183166T3 (es) 1996-04-26 2003-03-16 Massachusetts Inst Technology Ensayo de cribado por triple hibrido.
US5925523A (en) 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
WO1998016628A1 (en) 1996-10-15 1998-04-23 The Regents Of The University Of California Animal models of human prostate cancer progression
US5846722A (en) 1996-10-16 1998-12-08 Terrapin Technologies, Inc. System to detect small molecule/peptide interaction
EP2314625B1 (en) 1996-12-03 2014-05-07 Amgen Fremont Inc. Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom
ES2359401T3 (es) * 1997-08-01 2011-05-23 Merck Serono Biodevelopment ESTs 5¿PARA PROTEÍNAS SECRETADAS, EXPRESADAS EN DIVERSOS TEJIDOS.
WO1999006550A2 (en) * 1997-08-01 1999-02-11 Genset 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE
ES2267192T3 (es) * 1997-08-01 2007-03-01 Serono Genetics Institute S.A. Ests 5' para proteinas secretadas no especificas de tejido.
CA2328895A1 (en) * 1998-06-02 1999-12-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same

Similar Documents

Publication Publication Date Title
BE2014C009I2 (ja)
BE2012C026I2 (ja)
BE2010C018I2 (ja)
BE2010C009I2 (ja)
AU2000236815A8 (ja)
BRPI0112928B8 (ja)
JP2002535730A5 (ja)
JP2000228562A5 (ja)
BE2010C040I2 (ja)
JP2001176034A5 (ja)
JP2001222256A5 (ja)
JP2001272508A5 (ja)
JP2001051663A5 (ja)
BRPI0113372A8 (ja)
JP2002541800A5 (ja)
JP2002203773A5 (ja)
JP2002035307A5 (ja)
CH694022C1 (ja)
JP2001201673A5 (ja)
JP2001196066A5 (ja)
JP2001292593A5 (ja)
CL2006000179A1 (ja)
CN3139026S (ja)
AU2000280388A8 (ja)
CN3149762S (ja)